APELLIS PHARMACEUTICALS INC's ticker is APLS and the CUSIP is 03753U106. A total of 143 filers reported holding APELLIS PHARMACEUTICALS INC in Q2 2020. The put-call ratio across all filers is 1.36 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2021 | $3,464,000 | -25.6% | 80,727 | -0.8% | 2.81% | -20.9% |
Q4 2020 | $4,654,000 | +100.9% | 81,357 | +5.9% | 3.55% | +93.9% |
Q3 2020 | $2,317,000 | -4.7% | 76,804 | +3.2% | 1.83% | +7.5% |
Q2 2020 | $2,432,000 | +19.3% | 74,452 | 0.0% | 1.70% | -15.2% |
Q1 2020 | $2,038,000 | -11.5% | 74,452 | -1.0% | 2.01% | +30.0% |
Q4 2019 | $2,303,000 | – | 75,227 | – | 1.54% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Octagon Capital Advisors LP | 3,130,000 | $119,065,200 | 18.29% |
EcoR1 Capital, LLC | 10,899,859 | $414,630,636 | 13.99% |
Ally Bridge Group (NY) LLC | 181,805 | $6,915,862 | 8.12% |
Avoro Capital Advisors LLC | 11,111,111 | $422,666,662 | 6.59% |
ACUTA CAPITAL PARTNERS, LLC | 244,484 | $9,300,171 | 6.23% |
Iron Triangle Partners LP | 880,000 | $33,475,200 | 4.89% |
Cormorant Asset Management, LP | 2,000,000 | $76,080,000 | 4.44% |
Octagon Capital Advisors LP | 675,000 | $25,677,000 | 3.94% |
Logos Global Management LP | 750,000 | $28,530,000 | 3.81% |
Boxer Capital, LLC | 1,726,000 | $65,657,040 | 3.50% |